BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24969989)

  • 1. The chick chorioallantoic membrane: a model of short-term study of Dupuytren's disease.
    Mîndrilă I; Pârvănescu H; Pirici D; Niculescu M; Buteică SA; Taisescu O; Tarnita DN
    Rom J Morphol Embryol; 2014; 55(2):377-82. PubMed ID: 24969989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.
    Alfonso-Rodríguez CA; Garzón I; Garrido-Gómez J; Oliveira AC; Martín-Piedra MÁ; Scionti G; Carriel V; Hernández-Cortés P; Campos A; Alaminos M
    PLoS One; 2014; 9(11):e112457. PubMed ID: 25379672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupuytren's disease: comparative growth dynamics and morphology between cultured myofibroblasts (nodule) and fibroblasts (cord).
    Vande Berg JS; Gelberman RH; Rudolph R; Johnson D; Sicurello P
    J Orthop Res; 1984; 2(3):247-56. PubMed ID: 6491814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
    Ulrich D; Ulrich F; Piatkowski A; Pallua N
    Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.
    Verjee LS; Verhoekx JS; Chan JK; Krausgruber T; Nicolaidou V; Izadi D; Davidson D; Feldmann M; Midwood KS; Nanchahal J
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):E928-37. PubMed ID: 23431165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role of myofibroblasts in the pathogenesis of Dupuytren's contracture.
    Salamon A; Hámori J
    Acta Morphol Acad Sci Hung; 1980; 28(1-2):71-82. PubMed ID: 7192480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
    Verjee LS; Midwood K; Davidson D; Eastwood M; Nanchahal J
    J Cell Physiol; 2010 Sep; 224(3):681-90. PubMed ID: 20432463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
    Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
    Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of Dupuytren's contracture--a review].
    Koźma EM; Olczyk K; Bobiński R; Kasperczyk M; Szpyra K
    Chir Narzadow Ruchu Ortop Pol; 2002; 67(1):73-9. PubMed ID: 12087679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The myofibroblast in Dupuytren's contracture.
    Rudolph R; Vande Berg J
    Hand Clin; 1991 Nov; 7(4):683-92; discussion 693-4. PubMed ID: 1769990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palmar fascial complex anatomy and pathology in Dupuytren's disease.
    Rayan GM
    Hand Clin; 1999 Feb; 15(1):73-86, vi-vii. PubMed ID: 10050244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microanatomy of Dupuytren's contracture.
    McGrouther DA
    Hand; 1982 Oct; 14(3):215-36. PubMed ID: 7152372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anatomy of Dupuytren's disease.
    McFarlane RM
    Bull Hosp Jt Dis Orthop Inst; 1984; 44(2):318-37. PubMed ID: 6099177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
    Tomasek J; Rayan GM
    J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical and migratory properties of normal, scar, and Dupuytren's fibroblasts.
    Viji Babu PK; Rianna C; Belge G; Mirastschijski U; Radmacher M
    J Mol Recognit; 2018 Sep; 31(9):e2719. PubMed ID: 29701269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Dupuytren's disease of the palmar fascia.
    Rayan GM; Moore J
    J Hand Surg Br; 2005 Dec; 30(6):551-6. PubMed ID: 16203068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation into the role of inflammatory cells in Dupuytren's disease.
    Andrew JG; Andrew SM; Ash A; Turner B
    J Hand Surg Br; 1991 Aug; 16(3):267-71. PubMed ID: 1960491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.